1162 related articles for article (PubMed ID: 26853596)
21. Exploitation of lipid-polymeric matrices at nanoscale for drug delivery applications.
Sgorla D; Bunhak ÉJ; Cavalcanti OA; Fonte P; Sarmento B
Expert Opin Drug Deliv; 2016 Sep; 13(9):1301-9. PubMed ID: 27110648
[TBL] [Abstract][Full Text] [Related]
22. Superparamagnetic nanoparticles for biomedical applications.
Xiao Y; Du J
J Mater Chem B; 2020 Jan; 8(3):354-367. PubMed ID: 31868197
[TBL] [Abstract][Full Text] [Related]
23. Dual-responsive polymer coated superparamagnetic nanoparticle for targeted drug delivery and hyperthermia treatment.
Patra S; Roy E; Karfa P; Kumar S; Madhuri R; Sharma PK
ACS Appl Mater Interfaces; 2015 May; 7(17):9235-46. PubMed ID: 25893447
[TBL] [Abstract][Full Text] [Related]
24. Magnetic nanocarriers of doxorubicin coated with poly(ethylene glycol) and folic acid: relation between coating structure, surface properties, colloidal stability, and cancer cell targeting.
Kaaki K; Hervé-Aubert K; Chiper M; Shkilnyy A; Soucé M; Benoit R; Paillard A; Dubois P; Saboungi ML; Chourpa I
Langmuir; 2012 Jan; 28(2):1496-505. PubMed ID: 22172203
[TBL] [Abstract][Full Text] [Related]
25. Magnetic iron oxide nanoparticles as drug carriers: preparation, conjugation and delivery.
El-Boubbou K
Nanomedicine (Lond); 2018 Apr; 13(8):929-952. PubMed ID: 29546817
[TBL] [Abstract][Full Text] [Related]
26. Dendrimer functionalized magnetic nanoparticles as a promising platform for localized hyperthermia and magnetic resonance imaging diagnosis.
Esmaeili E; Khalili M; Sohi AN; Hosseinzadeh S; Taheri B; Soleimani M
J Cell Physiol; 2019 Aug; 234(8):12615-12624. PubMed ID: 30536886
[TBL] [Abstract][Full Text] [Related]
27. An update on the applications and characteristics of magnetic iron oxide nanoparticles for drug delivery.
Stanicki D; Vangijzegem T; Ternad I; Laurent S
Expert Opin Drug Deliv; 2022 Mar; 19(3):321-335. PubMed ID: 35202551
[TBL] [Abstract][Full Text] [Related]
28. Pegylated magnetic nanocarriers for doxorubicin delivery: a quantitative determination of stealthiness in vitro and in vivo.
Allard-Vannier E; Cohen-Jonathan S; Gautier J; Hervé-Aubert K; Munnier E; Soucé M; Legras P; Passirani C; Chourpa I
Eur J Pharm Biopharm; 2012 Aug; 81(3):498-505. PubMed ID: 22510695
[TBL] [Abstract][Full Text] [Related]
29. Targeting strategies for superparamagnetic iron oxide nanoparticles in cancer therapy.
Zhi D; Yang T; Yang J; Fu S; Zhang S
Acta Biomater; 2020 Jan; 102():13-34. PubMed ID: 31759124
[TBL] [Abstract][Full Text] [Related]
30. Design and construction of multifunctional hyperbranched polymers coated magnetite nanoparticles for both targeting magnetic resonance imaging and cancer therapy.
Mashhadi Malekzadeh A; Ramazani A; Tabatabaei Rezaei SJ; Niknejad H
J Colloid Interface Sci; 2017 Mar; 490():64-73. PubMed ID: 27870961
[TBL] [Abstract][Full Text] [Related]
31. PEG-stabilized core-shell nanoparticles: impact of linear versus dendritic polymer shell architecture on colloidal properties and the reversibility of temperature-induced aggregation.
Gillich T; Acikgöz C; Isa L; Schlüter AD; Spencer ND; Textor M
ACS Nano; 2013 Jan; 7(1):316-29. PubMed ID: 23214719
[TBL] [Abstract][Full Text] [Related]
32. Magnetic nanoparticles-based drug and gene delivery systems for the treatment of pulmonary diseases.
El-Sherbiny IM; Elbaz NM; Sedki M; Elgammal A; Yacoub MH
Nanomedicine (Lond); 2017 Feb; 12(4):387-402. PubMed ID: 28078950
[TBL] [Abstract][Full Text] [Related]
33. Recent advances in superparamagnetic iron oxide nanoparticles (SPIONs) for in vitro and in vivo cancer nanotheranostics.
Kandasamy G; Maity D
Int J Pharm; 2015 Dec; 496(2):191-218. PubMed ID: 26520409
[TBL] [Abstract][Full Text] [Related]
34. Synthesis of Superparamagnetic Iron Oxide Nanoparticles: SWOT Analysis Towards Their Conjugation to Biomolecules for Molecular Recognition Applications.
Salvador M; Moyano A; Martínez-García JC; Blanco-López MC; Rivas M
J Nanosci Nanotechnol; 2019 Aug; 19(8):4839-4856. PubMed ID: 30913798
[TBL] [Abstract][Full Text] [Related]
35. Magnetic nanoparticles for precision oncology: theranostic magnetic iron oxide nanoparticles for image-guided and targeted cancer therapy.
Zhu L; Zhou Z; Mao H; Yang L
Nanomedicine (Lond); 2017 Jan; 12(1):73-87. PubMed ID: 27876448
[TBL] [Abstract][Full Text] [Related]
36. Magnetic nanoparticle-based drug delivery for cancer therapy.
Tietze R; Zaloga J; Unterweger H; Lyer S; Friedrich RP; Janko C; Pöttler M; Dürr S; Alexiou C
Biochem Biophys Res Commun; 2015 Dec; 468(3):463-70. PubMed ID: 26271592
[TBL] [Abstract][Full Text] [Related]
37. Surface modification of iron oxide nanoparticles by biocompatible polymers for tissue imaging and targeting.
Muthiah M; Park IK; Cho CS
Biotechnol Adv; 2013 Dec; 31(8):1224-36. PubMed ID: 23528431
[TBL] [Abstract][Full Text] [Related]
38. DNA-Iron Oxide Nanoparticles Conjugates: Functional Magnetic Nanoplatforms in Biomedical Applications.
Sosa-Acosta JR; Iriarte-Mesa C; Ortega GA; Díaz-García AM
Top Curr Chem (Cham); 2020 Jan; 378(1):13. PubMed ID: 31925680
[TBL] [Abstract][Full Text] [Related]
39. Development and characterization of magnetic iron oxide nanoparticles with a cisplatin-bearing polymer coating for targeted drug delivery.
Unterweger H; Tietze R; Janko C; Zaloga J; Lyer S; Dürr S; Taccardi N; Goudouri OM; Hoppe A; Eberbeck D; Schubert DW; Boccaccini AR; Alexiou C
Int J Nanomedicine; 2014; 9():3659-76. PubMed ID: 25120363
[TBL] [Abstract][Full Text] [Related]
40. Advances in surface design and biomedical applications of magnetic nanoparticles.
Araújo EV; Carneiro SV; Neto DMA; Freire TM; Costa VM; Freire RM; Fechine LMUD; Clemente CS; Denardin JC; Dos Santos JCS; Santos-Oliveira R; Rocha JS; Fechine PBA
Adv Colloid Interface Sci; 2024 Jun; 328():103166. PubMed ID: 38728773
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
